OLYSIO 150 mg

OLYSIO 150 mg

OLYSIO

Simeprevir

Capusles :150 mg

Janssen Pharmaceutical.

Medical Use

OLYSIO is an NS3/4A protease inhibitor used to treat chronic hepatitis C (CHC) infection as part of a combination antiviral therapy regimen.

  • -The effectiveness of OLYSIO has been demonstrated when used with peginterferon alfa and ribavirin in patients with HCV genotype 1 and compensated liver disease, including cirrhosis.
  • -OLYSIO should not be used alone.
  • -It is highly recommended to screen patients with HCV genotype 1a for the NS3 Q80K polymorphism before starting treatment. If the Q80K polymorphism is present, consider alternative therapies.